Sharekhan

Fischer Medical Ventures Ltd

Fri 21/11/2025,15:59:13 | NSE : FISCHER

₹ 40.97-1.97 (-4.59%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 40.79

Previous Close

₹ 42.94

Volume

16224278

Mkt Cap ( Rs. Cr)

₹2656.97

High

₹ 43.80

Low

₹ 40.79

52 Week High

₹ 124.70

52 Week Low

₹ 40.79

Book Value Per Share

₹ 4.75

Dividend Yield

0.12

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Fischer Medical Ventures Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

43.01

218212

43.00

500

43.00

2322

43.00

200

42.00

100

Bid Total

868035

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Fischer Medical Ventures Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Fischer Medical Vent - Spurt in Volume

    21 Nov 2025, 6:18PM Significant increase in volume has been observed in Fischer Medical Ventures Limited. The Exchange, in order to ensure that investors have latest rele
  • Fischer Medical Vent - Press Release

    17 Nov 2025, 8:59AM Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of the Company announces New Low-Field TOF MRI Platform for Nationwide
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    17 Nov 2025, 9:06AM Time Medical International Ventures (I) P ltd, WOS of the Company announces the breakthrough new low field TOF MRI Platform for Aneurysm screening, de
  • Fischer Medical Vent - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Nov 2025, 4:00PM Fischer Medical Ventures Limited has informed the Exchange about Transcript
  • Fischer Medical Vent - Press Release

    13 Nov 2025, 10:02AM Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated November 13, 2025, titled ""Award of Order Worth ₹9.2
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    13 Nov 2025, 10:02AM Press release: Award of order worth Rs. 9.29 crore by the Tamil Nadu Animal Husbandry Department for supply and installation of 65 Digital Radiograph
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    13 Nov 2025, 4:09PM Transcript of the Earnings call for the Q2 FY25-26 is enclosed
  • Time Medical Wins Rs 9.29 cr Govt Tender to Supply Digital Radiography Units for Veterinary Healthcare in Tamil Nadu

    13 Nov 2025, 10:26AM Time Medical International Ventures (India) Pvt. Ltd. has secured a landmark government tender from the Tamil Nadu Animal Husbandry Department for the
  • Fischer Medical Vent - Press Release (Revised)

    11 Nov 2025, 1:26PM Fischer Medical Ventures Limited has informed the Exchange regarding a revised press release dated November 11, 2025, titled ""Province of Bulacan has
  • Fischer Medical Vent - Press Release

    11 Nov 2025, 11:12AM Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated November 11, 2025, titled ""Province of Bulacan has inaugur
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

    11 Nov 2025, 1:25PM Bulacan has inaugurated the Country's first locally funded MRI marketed by Time Medical Philippines Inc. and developed by Time Medical International V
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    11 Nov 2025, 11:09AM Bulacan leads the way with Philippines with inauguration of Country's first MRI facility developed by Time Medical Phillipines Inc. step down subsidi
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    7 Nov 2025, 3:43PM The link of the audio recording of the Earnings call for the Q2 is enclosed herewith.
  • Fischer Medical Vent - Analysts/Institutional Investor Meet/Con. Call Updates

    7 Nov 2025, 3:41PM Fischer Medical Ventures Limited has informed the Exchange about Link of Recording
  • Fischer Medical Vent - Press Release

    4 Nov 2025, 2:08PM Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated November 04, 2025, titled ""Time Medical International Vent
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    4 Nov 2025, 2:08PM Time Medical International Ventures (India) Pvt Ltd, the WOS of the Company announces the development of Inter-Op MRI under the leadership of Dr. Iype
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Meeting Updates

    3 Nov 2025, 5:57PM Fischer Medical Ventures Ltd has informed the exchange on the schedule of Analyst/ Investor conference call relating to Quarter 2 Financial Earnings /
  • Fischer Medical Vent - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Nov 2025, 5:52PM Fischer Medical Ventures Limited has informed the Exchange about Schedule of meet
  • FlynnCare Wins Silver Medal at ARCA 2025 in Zagreb for AI-Driven Preventive Health Platform

    3 Nov 2025, 11:32AM FlynnCare Health Innovations Pvt Ltd has won the Silver Medal at the 23rd International Innovations Exhibition – ARCA 2025, held from October 16
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    3 Nov 2025, 10:45AM Fischer Medical Ventures Wholly owned subsidiary Flynncare Health Innovations P Ltd wins silver medal at ARCA 2025, Zagreb
  • Fischer Medical Vent - Press Release

    3 Nov 2025, 10:40AM Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated November 03, 2025, titled ""Fischer Medical Ventures Wholly
  • Fischer Medical Vent - Copy of Newspaper Publication

    31 Oct 2025, 2:58PM Fischer Medical Ventures Limited has informed the Exchange about Copy of Newspaper Publication
  • Fischer Medical Vent - Update On Latest Corporate Presentation

    30 Oct 2025, 11:07PM Update on latest corporate presentation
  • Fischer Medical Vent - General Updates

    30 Oct 2025, 11:04PM Fischer Medical Ventures Limited has informed the Exchange about General Updates
  • Fischer Medical Vent - Shareholders meeting

    30 Oct 2025, 3:14PM Fischer Medical Ventures Limited has informed the Exchange regarding Notice of Postal Ballot
  • Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    30 Oct 2025, 3:14PM Notice of Postal Ballot enclosed herewith
  • Fischer Medical Vent - Press Release

    29 Oct 2025, 1:02PM Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated October 29, 2025, titled ""Press Release: Fischer Medical V
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    29 Oct 2025, 1:03PM Fischer Medical Ventures Ltd reports 123% YoY Surge in Total Income for Q2 FY 26
  • Fischer Medical Vent - Outcome of Board Meeting

    28 Oct 2025, 11:57PM Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
  • Fischer Medical Vent - General Updates

    28 Oct 2025, 9:49PM Fischer Medical Ventures Limited has informed the Exchange about General Updates
  • Fischer Medical Vent - Update On Material Subsidiary

    28 Oct 2025, 9:48PM Update on Material Subsidiary
  • Fischer Medical Vent - Shareholders meeting

    28 Oct 2025, 9:44PM Fischer Medical Ventures Limited has informed the Exchange about Shareholders meeting
  • Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    28 Oct 2025, 9:44PM Intimation of Postal Ballot for appointment of Independent Directors
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Change in Management

    28 Oct 2025, 9:34PM Fischer Medical Ventures Limited has informed the exchange on the appointment / recommendation of Independent Director
  • Fischer Medical Vent - Appointment

    28 Oct 2025, 9:30PM Fischer Medical Ventures Limited has informed the Exchange regarding Appointment of Mr Mr. Chan Sing En as Independent Director of the company w.e.f.
  • Fischer Medical Vent - Results - Financial Results 30.09.2025

    28 Oct 2025, 9:29PM Unaudited Financial Results dated 30.09.2025
  • Fischer Medical Vent - Outcome of Board Meeting

    28 Oct 2025, 9:23PM Fischer Medical Ventures Limited has informed the Exchange regarding Board meeting held on October 28, 2025.
  • Fischer Medical Vent - Board Meeting Outcome for Board Meeting Outcome

    28 Oct 2025, 9:23PM Fischer Medical Ventures Limited has informed the exchange on the Outcome of Board meeting held on 28/10/2025
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    24 Oct 2025, 11:52AM Monitoring Agency Report for the quarter ended 30.09.2025 is enclosed
  • Fischer Medical Vent - Monitoring Agency Report

    24 Oct 2025, 11:50AM Intimation of Monitoring Agency Report for the quarter ended 30.09.2025
  • Fischer Medical Vent - Press Release

    23 Oct 2025, 9:15AM Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated October 23, 2025, titled ""Press Release: Nanomedic Clears
  • Fischer Medical Vent - Board Meeting Intimation for Consideration And Approval Of Unaudited Quarterly Results For The Period

    23 Oct 2025, 12:00PM Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2025 ,inter alia, to cons
  • Nanomedic secures NHS Nod, Eyes India Launch and US FDA Filing

    23 Oct 2025, 9:34AM Fischer Medical Ventures Ltd. (FMVL) announced that its portfolio company, Nanomedic Technologies Ltd., has achieved key global milestones, including
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    23 Oct 2025, 9:14AM Press Release: Nanomedic clears UK NHS Hurdle, Launches India Market Strategy and targets US FDA Submission
  • Fischer Medical Vent - Press Release

    16 Oct 2025, 1:02PM Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated October 16, 2025, titled ""FMV Global Innovation PTE Ltd (F
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    16 Oct 2025, 1:02PM FMV Global Innovation Pte Ltd achieves full licensing status for Indonesia's landmark handheld X-Ray Government Tender
  • Fischer Medical Vent - General Updates

    16 Oct 2025, 12:54PM Fischer Medical Ventures Limited has informed the Exchange about General Updates
  • Fischer Medical Vent - Announcement Relating To Wholly Owned Subsidiary

    16 Oct 2025, 12:54PM Announcement relating to Wholly owned Subsidiary
  • Fischer Medical Vent - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Oct 2025, 12:40PM Certificate under Regulation 74(5) of SEBI DP Regulations
  • Fischer Medical Vent - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Oct 2025, 12:40PM Fischer Medical Ventures Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Fischer Medical Vent has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    8 Oct 2025, 2:51PM As of September 2025, 61.80% is owned by Promoters and 38.20% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 10.64% and
  • Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2025, 5:24PM Scrutinizer's Report along with Voting Results are enclosed herewith
  • Fischer Medical Vent - Shareholders meeting

    30 Sep 2025, 5:15PM Fischer Medical Ventures Limited has submitted the Exchange a copy Srutinizers report of undefined held on September 29, 2025
  • Fischer Medical Vent - Trading Window

    29 Sep 2025, 2:58PM Fischer Medical Ventures Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regu
  • Fischer Medical Vent - Shareholders meeting

    29 Sep 2025, 2:03PM Fischer Medical Ventures Limited has informed the Exchange regarding Proceedings of undefined held on September 29, 2025
  • Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2025, 5:24PM Scrutinizer's Report along with Voting Results are enclosed herewith
  • Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Outcome of AGM

    29 Sep 2025, 2:09PM The proceedings of the 32nd AGM is enclosed herewith.
  • Fischer Medical Vent - Reg. 34 (1) Annual Report.

    23 Sep 2025, 12:03PM Corrigendum to Annual Report of the Company for the financial year 2024-25.
  • Fischer Medical Vent has submitted to BSE the Shareholding Pattern for the Period Ended September 12, 2025

    18 Sep 2025, 12:10PM As of September 2025, 61.80% is owned by Promoters and 38.20% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 10.64% and
  • Fischer Medical Vent - General Updates

    16 Sep 2025, 10:45AM Fischer Medical Ventures Limited has informed the Exchange about General Updates
  • Fischer Medical Vent - Dividend Clarification

    16 Sep 2025, 10:40AM Clarification on dividend declared 0.5% on the face value Re. 1/-
  • Fischer Medical Vent - Copy of Newspaper Publication

    8 Sep 2025, 3:16PM Fischer Medical Ventures Limited has informed the Exchange about Copy of Newspaper Publication
  • Fischer Medical Vent - Record Date

    1 Sep 2025, 3:40PM Fischer Medical Ventures Limited has informed the Exchange that Record date for the purpose of Split/Subdivision is 12-Sep-2025.
  • Fischer Medical Vent - Shareholders meeting

    1 Sep 2025, 10:28AM Fischer Medical Ventures Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot
  • Fischer Medical Vent - The Company Has Fixed The 12Th September 2025 As The Record Date For The Purpose Of Determining The El

    1 Sep 2025, 3:43PM The Company has fixed the 12th September 2025 as the Record date for the purpose of determining the eligibility of members for sub-division/split of s
  • Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    1 Sep 2025, 10:36AM Fischer Medical Ventures Limited has informed the exchange on the voting results and scrutinizer report for the Postal Ballot concluded on 30th August

Key fundamentals

Evaluate the intrinsic value of Fischer Medical Ventures Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 335.685 79.6794 0.3057 0.1597 0.2359
Liabilities 335.685 79.6794 0.3057 0.1597 0.2359
Equity 63.8015 53.5 0.172 0.172 0.172
Gross Profit -2.2373 -0.1952 0.0152 -0.1887 -0.1825
Net Profit 0.6632 0.4028 -0.0365 -0.2326 0.1406
Cash From Operating Activities -24.1034 0.0796 -0.1459 -0.1769 -0.0573
NPM(%) 12.7 3.49 -20.33 0 0
Revenue 5.2196 11.5283 0.1795 0 0
Expenses 7.4569 11.7235 0.1643 0.1887 0.1825
ROE(%) 0.21 0.13 -0.01 -0.07 0.04

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Fischer Medical Ventures Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 799.35 3.36 15.96 369.90 337.37 1.13
Amines and Plasticizers Ltd 196.11 -0.23 29.85 225.58 372.61 0.25
Indogulf Cropsciences Ltd 93.66 -1.90 11.18 96.43 49.78 0.00
Grauer and Weil (India) Ltd 115.60 0.00 34.71 1858.99 346.70 0.43

Company Info

The Company was incorporated as a Public Limited Company on 22nd March 1993, and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemicals particularly after the delicensing of the industry,the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufacturing of Laboratory Grade Chemicals, for about 10 years. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam, near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS, SOLVENTS & ACIDS which include 1. Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2. Electronic Reagent Grade Chemicals (EL Grade) used in the Process of both Manufacturing & Assembling Electronic Industries. 3. IP Grade Chemicals used in Pharmaceutical Industries. 4. Diagnostic Grade Chemicals used in Hospitals/Clinical Laboratories for either Bio-Chemical or Histopathological Estimations. 2003 -Fischer Chem gets ISO 9001:2000 certification by M/s. RWTUV of Germany 2008 -Fischer Chemic has designated E-mail ID for Investors Complaints: fischerlab@vsnl.net 2013 -Company has changed its Registered Office from No. 3/240, Govindan Nagar, Palavakkam, Chennai - 600041, Tamilnadu to First Floor, Silver Sky Super Market Complex, New No. 15 Gangai Amman Koil Street, Kodambakkam, Chennai - 600 024, Tamilnadu.

The Company was incorporated as a Public Limited Company on 22nd March 1993, and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemicals particularly after the delicensing of the industry,the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufacturing of Laboratory Grade Chemicals, for about 10 years. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam, near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS, SOLVENTS & ACIDS which include 1. Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2. Electronic Reagent Grade Chemicals (EL Grade) used in the Process of both Manufacturing & Assembling Electronic Industries. 3. IP Grade Chemicals used in Pharmaceutical Industries. 4. Diagnostic Grade Chemicals used in Hospitals/Clinical Laboratories for either Bio-Chemical or Histopathological Estimations. 2003 -Fischer Chem gets ISO 9001:2000 certification by M/s. RWTUV of Germany 2008 -Fischer Chemic has designated E-mail ID for Investors Complaints: fischerlab@vsnl.net 2013 -Company has changed its Registered Office from No. 3/240, Govindan Nagar, Palavakkam, Chennai - 600041, Tamilnadu to First Floor, Silver Sky Super Market Complex, New No. 15 Gangai Amman Koil Street, Kodambakkam, Chennai - 600 024, Tamilnadu.

Read More

Parent Organisation

Fischer Medical Ventures Ltd.

Founded

22/03/1993

Managing Director

Mr.Ravindran Govindan

NSE Symbol

FISCHEREQ

FAQ

The current price of Fischer Medical Ventures Ltd is ₹ 40.97.

The 52-week high for Fischer Medical Ventures Ltd is ₹ 43.80 and the 52-week low is ₹ 40.79.

The market capitalization of Fischer Medical Ventures Ltd is currently ₹ 2656.97. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Fischer Medical Ventures Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Fischer Medical Ventures Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Fischer Medical Ventures Ltd shares.

The CEO of Fischer Medical Ventures Ltd is Mr.Ravindran Govindan, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT